BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 28504248)

  • 1. The flavonoid TL-2-8 induces cell death and immature mitophagy in breast cancer cells via abrogating the function of the AHA1/Hsp90 complex.
    Liu HJ; Jiang XX; Guo YZ; Sun FH; Kou XH; Bao Y; Zhang ZQ; Lin ZH; Ding TB; Jiang L; Lei XS; Yang YH
    Acta Pharmacol Sin; 2017 Oct; 38(10):1381-1393. PubMed ID: 28504248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-benzoquinone geldanamycin analogs trigger various forms of death in human breast cancer cells.
    Zhang Z; Li HM; Zhou C; Li Q; Ma L; Zhang Z; Sun Y; Wang L; Zhang X; Zhu B; Hong YS; Wu CZ; Liu H
    J Exp Clin Cancer Res; 2016 Sep; 35(1):149. PubMed ID: 27658586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triptolide inhibits human breast cancer MCF-7 cell growth via downregulation of the ERα-mediated signaling pathway.
    Li H; Pan GF; Jiang ZZ; Yang J; Sun LX; Zhang LY
    Acta Pharmacol Sin; 2015 May; 36(5):606-13. PubMed ID: 25864647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platycodin D, a metabolite of Platycodin grandiflorum, inhibits highly metastatic MDA-MB-231 breast cancer growth in vitro and in vivo by targeting the MDM2 oncogene.
    Kong Y; Lu ZL; Wang JJ; Zhou R; Guo J; Liu J; Sun HL; Wang H; Song W; Yang J; Xu HX
    Oncol Rep; 2016 Sep; 36(3):1447-56. PubMed ID: 27432230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of HIV protease inhibitor ritonavir on Akt-regulated cell proliferation in breast cancer.
    Srirangam A; Mitra R; Wang M; Gorski JC; Badve S; Baldridge L; Hamilton J; Kishimoto H; Hawes J; Li L; Orschell CM; Srour EF; Blum JS; Donner D; Sledge GW; Nakshatri H; Potter DA
    Clin Cancer Res; 2006 Mar; 12(6):1883-96. PubMed ID: 16551874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Debio-0932, a second generation oral Hsp90 inhibitor, induces apoptosis in MCF-7 and MDA-MB-231 cell lines.
    Özgür A; Kara A; Gökşen Tosun N; Tekin Ş; Gökçe İ
    Mol Biol Rep; 2021 Apr; 48(4):3439-3449. PubMed ID: 33999319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
    Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
    Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of anacardic acid, a Hsp90 inhibitor, on proliferation, invasion and migration of breast cancer MDA-MB-231 cells].
    Li H; Nie L; Huo Q; Zhao S; Ma T; Wu C; Liu H
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Mar; 35(3):355-9. PubMed ID: 25818779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3'-epi-12β-hydroxyfroside, a new cardenolide, induces cytoprotective autophagy via blocking the Hsp90/Akt/mTOR axis in lung cancer cells.
    Sun Y; Huang YH; Huang FY; Mei WL; Liu Q; Wang CC; Lin YY; Huang C; Li YN; Dai HF; Tan GH
    Theranostics; 2018; 8(7):2044-2060. PubMed ID: 29556372
    [No Abstract]   [Full Text] [Related]  

  • 10. Ginkgetin inhibits growth of breast carcinoma via regulating MAPKs pathway.
    Cao J; Tong C; Liu Y; Wang J; Ni X; Xiong MM
    Biomed Pharmacother; 2017 Dec; 96():450-458. PubMed ID: 29031204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apple Peel Flavonoid Fraction 4 Suppresses Breast Cancer Cell Growth by Cytostatic and Cytotoxic Mechanisms.
    Loung CY; Fernando W; Rupasinghe HPV; Hoskin DW
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31540221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of the anti-tumor activity of Methyl 2-(-5-fluoro-2-hydroxyphenyl)-1 H-benzo[d]imidazole-5-carboxylate against breast cancer in vitro and in vivo.
    Hasanpourghadi M; Pandurangan AK; Karthikeyan C; Trivedi P; Mustafa MR
    Oncotarget; 2017 Apr; 8(17):28840-28853. PubMed ID: 28392503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vivo Inhibition of Proteasome Activity and Tumour Growth by Murraya koenigii Leaf Extract in Breast Cancer Xenografts and by Its Active Flavonoids in Breast Cancer Cells.
    Noolu B; Gogulothu R; Bhat M; Qadri SS; Reddy VS; Reddy GB; Ismail A
    Anticancer Agents Med Chem; 2016; 16(12):1605-1614. PubMed ID: 27198988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bifunctional fused polypeptide inhibits the growth and metastasis of breast cancer.
    Liang AL; Qian HL; Zhang TT; Zhou N; Wang HJ; Men XT; Qi W; Zhang PP; Fu M; Liang X; Lin C; Liu YJ
    Drug Des Devel Ther; 2015; 9():5671-86. PubMed ID: 26527862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted inhibition of Hsp90 by ganetespib is effective across a broad spectrum of breast cancer subtypes.
    Friedland JC; Smith DL; Sang J; Acquaviva J; He S; Zhang C; Proia DA
    Invest New Drugs; 2014 Feb; 32(1):14-24. PubMed ID: 23686707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Arsenic trioxide restores ERα expression in ERα-negative human breast cancer cells and its treatment efficacy in combination with tamoxifen in xenografts in nude mice].
    Zhang WJ; Xu DF; Fan QX; Wu XA; Wang F; Wang R; Wang LX
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):645-51. PubMed ID: 23159075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of anticancer activities of Poria cocos ethanol extract in breast cancer: In vivo and in vitro, identification and mechanism.
    Jiang Y; Fan L
    J Ethnopharmacol; 2020 Jul; 257():112851. PubMed ID: 32283190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumour activity of the novel flavonoid Oncamex in preclinical breast cancer models.
    Martínez-Pérez C; Ward C; Turnbull AK; Mullen P; Cook G; Meehan J; Jarman EJ; Thomson PI; Campbell CJ; McPhail D; Harrison DJ; Langdon SP
    Br J Cancer; 2016 Apr; 114(8):905-16. PubMed ID: 27031849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cell survival, cell cycle progression, tumor growth and cyclooxygenase-2 activity in MDA-MB-231 breast cancer cells by camphorataimide B.
    Lin WL; Lee YJ; Wang SM; Huang PY; Tseng TH
    Eur J Pharmacol; 2012 Apr; 680(1-3):8-15. PubMed ID: 22329896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.